Aidoc Overview
Pro stress-test →Aidoc is a global leader in clinical AI focused on helping physicians make earlier, safer diagnoses by turning raw patient signals into actionable insight. The company's technology has analyzed more than 110 million patient cases and is deployed in nearly 2,000 hospitals worldwide, supporting clinical decision-making for approximately 60 million patients each year. Founded in 2016, Aidoc combines FDA-cleared diagnostic algorithms with an enterprise AI operating system (aiOS) to enable scaled deployment of clinical AI across health systems.
Strategic Profile
Pro stress-test →The company pioneered 'Always-on AI'—a type of artificial intelligence that constantly runs in the background and automatically analyzes medical imaging data, identifying urgent findings, and sparing radiologists from drowning in vast amounts of irrelevant data. The company is powered by its breakthrough CARE™ foundation model and an enterprise AI platform, Aidoc aiOS™, embedding AI directly into clinical workflows, enabling health systems to deploy, manage and scale multiple FDA-cleared solutions through a centralized operating layer. This positions Aidoc as a mission-critical infrastructure platform rather than a single-use diagnostic tool.
Competitive Landscape
Pro stress-test →Health systems consistently report tangible results including improved radiology efficiency, shorter lengths of stay, and measurable financial returns, with investors highlighting the company's combination of innovation, safety, technical rigor, and operational discipline. Key competitors include Zebra Medical Vision (radiology AI), Tempus (oncology AI), and Nuance/Microsoft (clinical documentation AI). Aidoc differentiates through breadth of FDA-cleared algorithms, enterprise platform approach (aiOS), and hospital-centric governance model.
Industry Context
Aidoc operates in Clinical AI platforms for medical imaging diagnostics.
Key facts
Founded: 2016 · Headquarters: Tel Aviv, US · Employees: N/A · Revenue: N/A · Market cap: N/A